Pharsight

Drug Patents Expiring in 2018

1. Bosulif patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6002008 PF PRISM CV Substituted 3-cyano quinolines
Mar, 2018

(6 years ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-163) Dec 19, 2024
Orphan Drug Exclusivity(ODE-444) Sep 26, 2030
New Indication(I-923) Sep 26, 2026
Pediatric Exclusivity(PED) Mar 26, 2027
New Indication(I-759) Dec 19, 2020
Orphan Drug Exclusivity(ODE) Sep 04, 2019
Orphan Drug Exclusivity(ODE-30) Sep 04, 2019
New Chemical Entity Exclusivity(NCE) Sep 04, 2017

Drugs and Companies using BOSUTINIB MONOHYDRATE ingredient

NCE-1 date: 26 March, 2026

Market Authorisation Date: 04 September, 2012

Treatment: A method of treating a neoplasm

Dosage: TABLET;ORAL

How can I launch a generic of BOSULIF before it's drug patent expiration?
More Information on Dosage

BOSULIF family patents

Family Patents

2. Brilinta patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6251910 ASTRAZENECA 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists
Jul, 2018

(5 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-848) Nov 05, 2023
M(M-283) May 09, 2025
Pediatric Exclusivity(PED) Nov 09, 2025
New Indication(I-851) May 28, 2023
New Strength(NS) Sep 03, 2018
New Indication(I-714) Sep 03, 2018
New Chemical Entity Exclusivity(NCE) Jul 20, 2016

Drugs and Companies using TICAGRELOR ingredient

NCE-1 date: 09 November, 2024

Market Authorisation Date: 03 September, 2015

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of BRILINTA before it's drug patent expiration?
More Information on Dosage

BRILINTA family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Eligard Kit patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9254307 TOLMAR Polymeric delivery formulations of leuprolide with improved efficacy
Oct, 2018

(5 years ago)

US9283282 TOLMAR Sustained release polymer
Oct, 2018

(5 years ago)

US8486455 TOLMAR Polymeric delivery formulations of leuprolide with improved efficacy
Oct, 2018

(5 years ago)

Drugs and Companies using LEUPROLIDE ACETATE ingredient

Market Authorisation Date: 23 January, 2002

Treatment: NA

Dosage: POWDER;SUBCUTANEOUS

More Information on Dosage

ELIGARD KIT family patents

Family Patents

4. Emend patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6096742 MSD MERCK CO Polymorphic form of a tachykinin receptor antagonist
Jul, 2018

(5 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Aug 28, 2018

Drugs and Companies using APREPITANT ingredient

Market Authorisation Date: 17 December, 2015

Treatment: Prevention of nausea and vomiting associated with chemotherapy (cinv)

Dosage: FOR SUSPENSION;ORAL

How can I launch a generic of EMEND before it's drug patent expiration?
More Information on Dosage

EMEND family patents

Family Patents

5. Evotaz patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6087383 BRISTOL Bisulfate salt of HIV protease inhibitor
Dec, 2018

(5 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Aug 27, 2017

Drugs and Companies using ATAZANAVIR SULFATE; COBICISTAT ingredient

NCE-1 date: 27 August, 2016

Market Authorisation Date: 29 January, 2015

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of EVOTAZ before it's drug patent expiration?
More Information on Dosage

EVOTAZ family patents

Family Patents

6. Gilotrif patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6251912 BOEHRINGER INGELHEIM Substituted quinazoline derivatives
Jul, 2018

(5 years ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-230) Jan 12, 2025
M(M-276) Apr 07, 2025
Pediatric Exclusivity(PED) Oct 07, 2025
Orphan Drug Exclusivity(ODE) Apr 15, 2023
New Chemical Entity Exclusivity(NCE) Jul 12, 2018
New Indication(I-730) Apr 15, 2019
Orphan Drug Exclusivity(ODE-115) Apr 15, 2023
New Indication(I-763) Jan 12, 2021
Orphan Drug Exclusivity(ODE-50) Jul 12, 2020

Drugs and Companies using AFATINIB DIMALEATE ingredient

NCE-1 date: 07 October, 2024

Market Authorisation Date: 12 July, 2013

Treatment: Treatment of cancer

Dosage: TABLET;ORAL

How can I launch a generic of GILOTRIF before it's drug patent expiration?
More Information on Dosage

GILOTRIF family patents

Family Patents

7. Gleevec patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
USRE43932 NOVARTIS Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
Jul, 2018

(5 years ago)

Drugs and Companies using IMATINIB MESYLATE ingredient

Market Authorisation Date: 10 May, 2001

Treatment: NA

Dosage: CAPSULE;ORAL

How can I launch a generic of GLEEVEC before it's drug patent expiration?
More Information on Dosage

GLEEVEC family patents

Family Patents

8. Latuda patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US5532372 SUNOVION PHARMS INC Imide derivatives, and their production and use
Jul, 2018

(5 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Dosing Schedule(D-134) Apr 26, 2015
New Chemical Entity Exclusivity(NCE) Oct 28, 2015
M(M-195) Jan 27, 2020
New Patient Population(NPP) Mar 05, 2021
New Indication(I-674) Jun 28, 2016
Pediatric Exclusivity(PED) Jul 27, 2020

Drugs and Companies using LURASIDONE HYDROCHLORIDE ingredient

NCE-1 date: 28 July, 2019

Market Authorisation Date: 07 December, 2011

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of LATUDA before it's drug patent expiration?
More Information on Dosage

LATUDA family patents

Family Patents

9. Lyrica Cr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6197819 UPJOHN Gamma amino butyric acid analogs and optical isomers
Dec, 2018

(5 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Oct 11, 2020
Pediatric Exclusivity(PED) Apr 11, 2021

Drugs and Companies using PREGABALIN ingredient

Market Authorisation Date: 11 October, 2017

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of LYRICA CR before it's drug patent expiration?
More Information on Dosage

LYRICA CR family patents

Family Patents

10. Nexium 24hr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7411070 ASTRAZENECA LP Form of S-omeprazole
May, 2018

(6 years ago)

US6369085 ASTRAZENECA LP Form of S-omeprazole
May, 2018

(6 years ago)

Drugs and Companies using ESOMEPRAZOLE MAGNESIUM ingredient

Market Authorisation Date: 23 November, 2015

Treatment: Method of treating frequent heartburn by administering an esomeprazole magnesium trihydrate as claimed

Dosage: TABLET, DELAYED RELEASE;ORAL

How can I launch a generic of NEXIUM 24HR before it's drug patent expiration?
More Information on Dosage

NEXIUM 24HR family patents

Family Patents

11. Otezla patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6020358 AMGEN INC Substituted phenethylsulfones and method of reducing TNFα levels
Oct, 2018

(5 years ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-248) Jul 19, 2026
New Indication(I-884) Dec 20, 2024
M(M-299) Jul 20, 2026
New Chemical Entity Exclusivity(NCE) Mar 21, 2019
New Indication(I-694) Sep 23, 2017
New Indication(I-803) Jul 19, 2022
M(M-257) Apr 10, 2023

Drugs and Companies using APREMILAST ingredient

NCE-1 date: 21 March, 2018

Market Authorisation Date: 21 March, 2014

Treatment: Use of otezla (apremilast) for inhibiting pde4

Dosage: TABLET;ORAL

How can I launch a generic of OTEZLA before it's drug patent expiration?
More Information on Dosage

OTEZLA family patents

Family Patents

12. Promacta Kit patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6280959 NOVARTIS Metal complexes
Oct, 2018

(5 years ago)

Drug Exclusivity Drug Exclusivity Expiration
ODE*(ODE*) Nov 16, 2025
New Dosing Schedule(D-149) Jun 11, 2018
New Indication(I-711) Jun 11, 2018
Orphan Drug Exclusivity(ODE) Aug 26, 2021
Pediatric Exclusivity(PED) Feb 26, 2022
Orphan Drug Exclusivity(ODE-74) Aug 26, 2021

Drugs and Companies using ELTROMBOPAG OLAMINE ingredient

Market Authorisation Date: 27 September, 2018

Treatment: Treatment of thrombocytopenia in adult and pediatric patients 1 year and older with chronic immune (idiopathic) thrombocytopenia (itp)

Dosage: FOR SUSPENSION;ORAL

How can I launch a generic of PROMACTA KIT before it's drug patent expiration?
More Information on Dosage

PROMACTA KIT family patents

Family Patents

13. Reyataz patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6087383 BRISTOL MYERS SQUIBB Bisulfate salt of HIV protease inhibitor
Dec, 2018

(5 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Jun 02, 2017
New Patient Population(NPP) Sep 24, 2018
Pediatric Exclusivity(PED) Mar 24, 2019

Drugs and Companies using ATAZANAVIR SULFATE ingredient

Market Authorisation Date: 02 June, 2014

Treatment: NA

Dosage: POWDER;ORAL

How can I launch a generic of REYATAZ before it's drug patent expiration?
More Information on Dosage

REYATAZ family patents

Family Patents

14. Spiriva Respimat patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
USRE39820 BOEHRINGER INGELHEIM Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
Jan, 2018

(6 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Sep 24, 2017
New Patient Population(NPP) Feb 15, 2020
Pediatric Exclusivity(PED) Aug 15, 2020

Drugs and Companies using TIOTROPIUM BROMIDE ingredient

Market Authorisation Date: 15 September, 2015

Treatment: Maintenance treatment of bronchospasm associated with copd, including chronic bronchitis and emphysema, and reduction of exacerbations in copd patients.

Dosage: SPRAY, METERED;INHALATION

How can I launch a generic of SPIRIVA RESPIMAT before it's drug patent expiration?
More Information on Dosage

SPIRIVA RESPIMAT family patents

Family Patents

15. Stiolto Respimat patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
USRE39820 BOEHRINGER INGELHEIM Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
Jan, 2018

(6 years ago)

Drug Exclusivity Drug Exclusivity Expiration
M(M-233) Oct 05, 2021
New Combination(NC) May 21, 2018
New Chemical Entity Exclusivity(NCE) Jul 31, 2019
M(M-173) Mar 18, 2019

Drugs and Companies using OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE ingredient

NCE-1 date: 31 July, 2018

Market Authorisation Date: 21 May, 2015

Treatment: Treatment of copd

Dosage: SPRAY, METERED;INHALATION

More Information on Dosage

STIOLTO RESPIMAT family patents

Family Patents

16. Triumeq patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6294540 VIIV HLTHCARE Carbocyclic nucleoside hemisulfate and its use in treating viral infections
May, 2018

(6 years ago)

Drug Exclusivity Drug Exclusivity Expiration
M(M-294) Jun 15, 2026
Pediatric Exclusivity(PED) Dec 15, 2026
New Chemical Entity Exclusivity(NCE) Aug 12, 2018
New Dosing Schedule(D-147) Mar 23, 2018

Drugs and Companies using ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE ingredient

NCE-1 date: 15 December, 2025

Market Authorisation Date: 22 August, 2014

Treatment: Treatment of human immunodeficiency virus (hiv) infection.

Dosage: TABLET;ORAL

How can I launch a generic of TRIUMEQ before it's drug patent expiration?
More Information on Dosage

TRIUMEQ family patents

Family Patents

17. Vyzulta patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6211233 BAUSCH AND LOMB Prostaglandin pharmaceutical compositions
Jun, 2018

(5 years ago)

Drugs and Companies using LATANOPROSTENE BUNOD ingredient

Market Authorisation Date: 02 November, 2017

Treatment: NA

Dosage: SOLUTION/DROPS;OPHTHALMIC

How can I launch a generic of VYZULTA before it's drug patent expiration?
More Information on Dosage

VYZULTA family patents

Family Patents

List of large molecules

1. List of Erbitux large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US6217866 NA Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
Feb, 2018

(6 years ago)

Ingredients: CETUXIMAB

2. List of Avastin large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US6054297 NA Humanized antibodies and methods for making them
Feb, 2018

(6 years ago)

Ingredients: RECOMBINANT HUMANIZED MONOCLONAL IGG1 ANTIBODY

3. List of Atryn large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US6441145 NA Transgenically produced Antithrombin III
Aug, 2018

(5 years ago)

Ingredients: ANTITHROMBIN